Predictive clinico-pathological factors to identify BCG, unresponsive patients, after re-resection for T1 high grade non-muscle invasive bladder cancer

Cancer <scp>I</scp>ncidence in <scp>F</scp>ive <scp>C</scp>ontinents: Inclusion criteria, highlights from Volume X and the global status of cancer registration

Freddie Bray, Jacques Ferlay, Mathieu Laversanne et al. · International Journal of Cancer · 2015 · 641 citations · Full text

EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non–Muscle-invasive Stage Ta–T1 Urothelial Bladder Cancer Patients Treated with 1–3 Years of Maintenance Bacillus Calmette-Guérin

Samantha Cambier, Richard Sylvester, Laurence Collette et al. · European Urology · 2015 · 616 citations · Full text

Eortc Nomograms, Prognostic Biomarkers, Urology +10

European Association of Urology (EAU) Prognostic Factor Risk Groups for Non–muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel

Richard Sylvester, Óscar Rodríguez, Virginia Hernández et al. · European Urology · 2021 · 415 citations

Urological Research, Urology, Cancer Risk +12

Prognostic Factors in Patients with Non–Muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin: Multivariate Analysis of Data from Four Randomized CUETO Trials

J.M. Fernández Gómez, Eduardo Solsona, Miguel Unda et al. · European Urology · 2007 · 254 citations · Full text

Prognostic Factors, Urology, Bacillus Calmette-guérin +9

RESTAGING TRANSURETHRAL RESECTION OF HIGH RISK SUPERFICIAL BLADDER CANCER IMPROVES THE INITIAL RESPONSE TO BACILLUS CALMETTE-GUERIN THERAPY

Harry W. Herr · The Journal of Urology · 2005 · 190 citations